Heparin-Induced Thrombocytopenia

ACCP Heparin-Induced Thrombocytopenia

ACCP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/61601

Contents of this Issue

Navigation

Page 9 of 11

Treatment Figure 3. Acute or Subacute HIT in Special Situations Bivalirudin (2C) Urgent cardiac surgery Nonurgent cardiac surgery PCI Renal replacement Pregnancy * Not available in the US. Cardiac surgery (+) antibodies Cardiac surgery (-) antibodies Cardiac cath or PCI (-) antibodies thrombosis and normal renal function Acute non-HIT Renal replacement or catheter locking Figure 4. Past History of HIT Nonheparin Delay surgery if possible until HIT has resolved and HIT antibodies are negative (2C) Bivalirudin (2B) or argatroban (2C) danaparoid* (2C) Argatroban or If unavailable: lepirudin or fondaparinux (2C) Danaparoid* (2C) anticoagulants (2C) Short-term heparin (2C) Bivalirudin (2B) or argatroban (2C) Fondaparinux (full dose) and transition to VKA (2C) Regional citrate (2C)

Articles in this issue

Archives of this issue

view archives of Heparin-Induced Thrombocytopenia - ACCP Heparin-Induced Thrombocytopenia